Compare Abbott Laboratories (ABT) vs Rent the Runway Inc (RENT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs Rent the Runway Inc — how do they compare? Abbott Laboratories trades at $95.59 (market cap $166.94B), while Rent the Runway Inc trades at $3.4 (market cap $115.40M). The key difference: Abbott Laboratories is far larger — about 1446.6× Rent the Runway Inc's market cap, and Abbott Laboratories pays a 2.63% dividend while Rent the Runway Inc pays none. Which is the better fit depends on your goals.
| ABT | RENT | |
|---|---|---|
Market Cap | $166.94B | $115.40M |
Sector | Health | Consumer Cyclical |
52-Week High | $136.62 | $9.39 |
52-Week Low | $82.57 | $3.10 |
Enterprise Value | $193.69B | $275.50M |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
RENT trades at $3.42, down 0.87% on the day, with a bearish technical signal. The company reported Q1 2026 revenue of $89.9 million, up 29.2% year-over-year, but continues to post net losses. Valuation ratios appear low with a P/E of 0.43 and P/S of 0.18, while negative equity of -$182.5 million and high debt levels pose financial risks. Recent leadership changes include the appointment of an interim CEO.
The outlook is mixed: strong revenue growth and low valuations suggest potential upside, but persistent losses, negative equity, and high leverage present significant risks. Analyst consensus is divided with 42% buy ratings, though no sell ratings exist. The stock's direction hinges on achieving profitability and managing debt.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About Rent the Runway Inc
Rent the Runway Inc is an e-commerce platform that allows users to rent, subscribe, or buy designer apparel and accessories.
Read more on RENT →
